Indeed, the effectiveness of IVIg therapy for such patients has been demonstrated.[7,8] A causal relationship should generally not be considered in patients with non-IgM M proteins with peripheral neuropathy and features not resembling CIDP. Here, PROS1 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.